Table 2. Correlation of CD133⁺ EVs and patients’ clinical parameters.

		No	CD133+ EVs T1	p*	CD133+ EVs T7	p*
Ischemia (h)	<15	12	4.38 [0.49–11.88]	0.936	8.41[0.00–56.03]	0.503
	>15	13	6.13 [0.28–31.82]		8.00 [0.00–68.68]
CNI introduction	ab initio	7	5.37 [0.51–11.88]	0.836	11.23 [1.48–62.29]	0.389
	at Crt<2.5	18	5.86 [0.28–31.82]		7.93 [0.00–68.68]
HLA Mismatches	<4	12	5.48 [0.28–31.82]	0.852	4.24 [0.00–68.68]	0.087
	>4	13	6.13 [0.49–12.88]		8.69 [1.48–62.29]
Pre-transplant diuresis	>1 L	11	6.65 [0.28–31.82]	0.085	11.77 [0.34–68.68]	0.166
	<1 L	14	2.81 [0.49–12.88]		6.51 [0.00–62.26]

No correlation was found among CD133⁺ EVs and ischemia time, introduction of calcineurin inhibitors (CNI), HLA mismatches, and pre-transplant diuresis. Data are expressed are median [min-max], p* = Mann-Withney test.